Susquehanna International Group’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.2K | Buy |
+20,023
| New | +$27.2K | ﹤0.01% | 6117 |
|
|
2025
Q1 | – | Sell |
-17,364
| Closed | -$22.2K | – | 6494 |
|
|
2024
Q4 | $22.2K | Sell |
17,364
-7,982
| -31% | -$10.2K | ﹤0.01% | 5989 |
|
|
2024
Q3 | $50.2K | Sell |
25,346
-40,834
| -62% | -$80.9K | ﹤0.01% | 5287 |
|
|
2024
Q2 | $134K | Buy |
66,180
+20,511
| +45% | +$41.4K | ﹤0.01% | 4981 |
|
|
2024
Q1 | $82.7K | Buy |
+45,669
| New | +$82.7K | ﹤0.01% | 5061 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6034 |
|
|
2023
Q3 | – | Sell |
-36,613
| Closed | -$32.6K | – | 5676 |
|
|
2023
Q2 | $32.6K | Sell |
36,613
-69,864
| -66% | -$62.2K | ﹤0.01% | 5283 |
|
|
2023
Q1 | $51.9K | Buy |
+106,477
| New | +$51.9K | ﹤0.01% | 5435 |
|
|
2022
Q4 | – | Sell |
-19,226
| Closed | -$20K | – | 5966 |
|
|
2022
Q3 | $20K | Buy |
19,226
+5,632
| +41% | +$5.86K | ﹤0.01% | 5712 |
|
|
2022
Q2 | $18K | Buy |
13,594
+644
| +5% | +$853 | ﹤0.01% | 5426 |
|
|
2022
Q1 | $20K | Buy |
+12,950
| New | +$20K | ﹤0.01% | 5467 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5905 |
|